{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:36:58Z","timestamp":1794980218505,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32201131"],"award-info":[{"award-number":["32201131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hainan Provincial Joint Project of Sanya Yazhou Bay Science and Technology City","award":["820LH026"],"award-info":[{"award-number":["820LH026"]}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2022M710990"],"award-info":[{"award-number":["2022M710990"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Hainan University Scientific Research Foundation","award":["KYQD(ZR)20078"],"award-info":[{"award-number":["KYQD(ZR)20078"]}]},{"DOI":"10.13039\/501100013314","name":"111 Project","doi-asserted-by":"crossref","award":["D22022"],"award-info":[{"award-number":["D22022"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Innovation Fund of WNLO"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sentinel lymph node (SLN) metastasis is an important promoter of distant metastasis in breast cancer. Therefore, the timely diagnosis and precise treatment are crucial for patient staging and prognosis. However, the simultaneous diagnosis of metastasis and the implementation of imaging-guided SLN therapy is challenging. Here, we report a melittin-loaded and hyaluronic acid (HA)-conjugated high-density lipoprotein (HDL) mimic phospholipid scaffold nanoparticle (MLT-HA-HPPS), which dually-target to both breast cancer and its SLN and efficiently inhibit SLN metastasis in the LN metastasis model. The melittin peptide was successfully loaded onto HA-HPPS via electrostatic interactions, and MLT-HA-HPPS possesses effective cytotoxicity for breast cancer 4T1 cells. Moreover, the effective delivery of MLT-HA-HPPS from the primary tumor into SLN is monitored by NIR fluorescence imaging, which greatly benefits the prognosis and treatment of metastatic SLNs. After paracancerous administration, MLT-HA-HPPS can efficiently inhibit primary tumor growth with an inhibition rate of 81.3% and 76.5% relative to the PBS-treated control group and HA-HPPS group, respectively. More importantly, MLT-HA-HPPS can effectively inhibit the growth of the metastatic SLNs with an approximately 78.0%, 79.1%, and 64.2% decrease in SLNs weight than those in PBS, HA-HPPS, and melittin-treated mice, respectively. Taken together, the MLT-HA-HPPS may provide an encouraging theranostic of SLN drug delivery strategy to inhibit primary tumor progression and prevent SLN metastasis of breast cancer.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-023-02026-7","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:02:40Z","timestamp":1690880560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles"],"prefix":"10.1186","volume":"21","author":[{"given":"Yanfeng","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhou","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"issue":"3","key":"2026_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA: A Cancer J Clin"},{"issue":"2","key":"2026_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11427-021-2009-0","volume":"65","author":"J Zhou","year":"2022","unstructured":"Zhou J, Yang W, Liu Q. Cancer challenges worldwide and in China: preparing for the inevitable. Sci China Life Sci. 2022;65(2):442\u20134.","journal-title":"Sci China Life Sci"},{"issue":"6024","key":"2026_CR3","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559\u201364.","journal-title":"Science"},{"issue":"1","key":"2026_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh K, Massagu\u00e9 J. Targeting metastatic cancer. Nat Med. 2021;27(1):34\u201344.","journal-title":"Nat Med"},{"issue":"1","key":"2026_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10585-021-10123-w","volume":"39","author":"SP Leong","year":"2022","unstructured":"Leong SP, Pissas A, Scarato M, Gallon F, Pissas MH, Amore M, Wu M, Faries MB, Lund AW. The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis. Clin Exp Metastasis. 2022;39(1):139\u201357.","journal-title":"Clin Exp Metastasis"},{"issue":"6382","key":"2026_CR6","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1126\/science.aal3662","volume":"359","author":"M Brown","year":"2018","unstructured":"Brown M, Assen FP, Leithner A, Abe J, Schachner H, Asfour G, Bago-Horvath Z, Stein JV, Uhrin P, Sixt M, et al. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science. 2018;359(6382):1408\u201311.","journal-title":"Science"},{"issue":"11","key":"2026_CR7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/annonc\/mdn386","volume":"19","author":"R Demicheli","year":"2008","unstructured":"Demicheli R, Retsky MW, Hrushesky WJM, Baum M, Gukas ID. The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008;19(11):1821\u20138.","journal-title":"Ann Oncol"},{"issue":"1","key":"2026_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.critrevonc.2013.07.008","volume":"89","author":"W Ceelen","year":"2014","unstructured":"Ceelen W, Pattyn P, Mareel M. Surgery, wound healing, and metastasis: recent insights and clinical implications. Crit Rev Oncol Hematol. 2014;89(1):16\u201326.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"27","key":"2026_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1200\/jco.2012.30.27_suppl.97","volume":"30","author":"MA Bello","year":"2012","unstructured":"Bello MA, Bergmann A, Dias R, Thuler LCS, Tonellotto F, Pinto RR, Fabro E. Incidence complications following sentinel lymph node biopsy or axillary lymph node dissection after breast cancer surgery. J Clin Oncol. 2012;30(27):97\u201397.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2026_CR10","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1007\/s00018-021-03842-6","volume":"78","author":"X Peng","year":"2021","unstructured":"Peng X, Wang J, Zhou F, Liu Q, Zhang Z. Nanoparticle-based approaches to target the lymphatic system for antitumor treatment. Cell Mol Life Sci. 2021;78(12):5139\u201361.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"2026_CR11","doi-asserted-by":"publisher","first-page":"2003972","DOI":"10.1002\/advs.202003972","volume":"8","author":"X Fan","year":"2021","unstructured":"Fan X, Li Y, Feng Z, Chen G, Zhou J, He M, Wu L, Li S, Qian J, Lin H. Nanoprobes-assisted multichannel NIR-II fluorescence imaging-guided resection and photothermal ablation of lymph nodes. Adv Sci. 2021;8(9):2003972.","journal-title":"Adv Sci"},{"issue":"1","key":"2026_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12951-021-01186-8","volume":"19","author":"W Liu","year":"2021","unstructured":"Liu W, Ye X, He L, Cheng J, Luo W, Zheng M, Hu Y, Zhang W, Cao Y, Ran H, et al. A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery. J Nanobiotechnol. 2021;19(1):432.","journal-title":"J Nanobiotechnol"},{"issue":"10","key":"2026_CR13","doi-asserted-by":"publisher","first-page":"16019","DOI":"10.1021\/acsnano.2c03752","volume":"16","author":"Z Pang","year":"2022","unstructured":"Pang Z, Yan W, Yang J, Li Q, Guo Y, Zhou D, Jiang X. Multifunctional gold nanoclusters for effective targeting, near-infrared fluorescence imaging, diagnosis, and treatment of cancer lymphatic metastasis. ACS Nano. 2022;16(10):16019\u201337.","journal-title":"ACS Nano"},{"issue":"11","key":"2026_CR14","doi-asserted-by":"publisher","first-page":"1907365","DOI":"10.1002\/adma.201907365","volume":"32","author":"R Tian","year":"2020","unstructured":"Tian R, Ma H, Zhu S, Lau J, Ma R, Liu Y, Lin L, Chandra S, Wang S, Zhu X, et al. Multiplexed NIR-II probes for lymph node-invaded cancer detection and imaging-guided surgery. Adv Mater. 2020;32(11):1907365.","journal-title":"Adv Mater"},{"issue":"8","key":"2026_CR15","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1021\/acsnano.9b03472","volume":"13","author":"J Liu","year":"2019","unstructured":"Liu J, Li H-J, Luo Y-L, Xu C-F, Du X-J, Du J-Z, Wang J. Enhanced primary tumor penetration facilitates nanoparticle draining into lymph nodes after systemic injection for tumor metastasis inhibition. ACS Nano. 2019;13(8):8648\u201358.","journal-title":"ACS Nano"},{"issue":"5","key":"2026_CR16","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1021\/nn5070259","volume":"9","author":"H Cabral","year":"2015","unstructured":"Cabral H, Makino J, Matsumoto Y, Mi P, Wu H, Nomoto T, Toh K, Yamada N, Higuchi Y, Konishi S, et al. Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers. ACS Nano. 2015;9(5):4957\u201367.","journal-title":"ACS Nano"},{"key":"2026_CR17","doi-asserted-by":"publisher","first-page":"101004","DOI":"10.1016\/j.nantod.2020.101004","volume":"36","author":"X Kong","year":"2021","unstructured":"Kong X, Cheng R, Wang J, Fang Y, Hwang KC. Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications. Nano Today. 2021;36:101004.","journal-title":"Nano Today"},{"issue":"22","key":"2026_CR18","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1177\/15353702211010762","volume":"246","author":"N Trac","year":"2021","unstructured":"Trac N, Chung EJ. Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes. Exp Biol Med. 2021;246(22):2358\u201371.","journal-title":"Exp Biol Med"},{"key":"2026_CR19","doi-asserted-by":"publisher","first-page":"216066","DOI":"10.1016\/j.canlet.2023.216066","volume":"556","author":"M Hegde","year":"2023","unstructured":"Hegde M, Naliyadhara N, Unnikrishnan J, Alqahtani MS, Abbas M, Girisa S, Sethi G, Kunnumakkara AB. Nanoparticles in the diagnosis and treatment of cancer metastases: current and future perspectives. Cancer Lett. 2023;556:216066.","journal-title":"Cancer Lett"},{"issue":"5574","key":"2026_CR20","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1126\/science.1071420","volume":"296","author":"TP Padera","year":"2002","unstructured":"Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002;296(5574):1883\u20136.","journal-title":"Science"},{"issue":"8","key":"2026_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.4161\/cc.5.8.2646","volume":"5","author":"SY Wong","year":"2006","unstructured":"Wong SY, Hynes RO. Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle. 2006;5(8):812\u20137.","journal-title":"Cell Cycle"},{"issue":"32","key":"2026_CR22","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1002\/adma.201401825","volume":"26","author":"C Liang","year":"2014","unstructured":"Liang C, Diao S, Wang C, Gong H, Liu T, Hong G, Shi X, Dai H, Liu Z. Tumor metastasis inhibition by imaging-guided photothermal therapy with single-walled carbon nanotubes. Adv Mater. 2014;26(32):5646\u201352.","journal-title":"Adv Mater"},{"issue":"13","key":"2026_CR23","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.7150\/thno.25608","volume":"8","author":"H Hu","year":"2018","unstructured":"Hu H, Wang J, Wang H, Tan T, Li J, Wang Z, Sun K, Li Y, Zhang Z. Cell-penetrating peptide-based nanovehicles potentiate lymph metastasis targeting and deep penetration for anti-metastasis therapy. Theranostics. 2018;8(13):3597\u2013610.","journal-title":"Theranostics"},{"key":"2026_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204184","author":"Z Liu","year":"2023","unstructured":"Liu Z, Fan Z, Liu J, Wang J, Xu M, Li X, Xu Y, Lu Y, Han C, Zhang Z. Melittin-carrying nanoparticle suppress T cell-driven immunity in a murine allergic dermatitis model. Adv Sci. 2023;10, 2204184.","journal-title":"Adv Sci"},{"issue":"11","key":"2026_CR25","doi-asserted-by":"publisher","first-page":"12638","DOI":"10.1021\/acsnano.9b04181","volume":"13","author":"H Liu","year":"2019","unstructured":"Liu H, Hu Y, Sun Y, Wan C, Zhang Z, Dai X, Lin Z, He Q, Yang Z, Huang P, et al. Co-delivery of bee venom melittin and a photosensitizer with an organic-inorganic hybrid nanocarrier for photodynamic therapy and immunotherapy. ACS Nano. 2019;13(11):12638\u201352.","journal-title":"ACS Nano"},{"issue":"1","key":"2026_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133","volume":"28","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Chen X, Gueydan C, Han J. Plasma membrane changes during programmed cell deaths. Cell Res. 2018;28(1):9\u201321.","journal-title":"Cell Res"},{"issue":"3","key":"2026_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/smll.200901515","volume":"6","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Chen J, Ding L, Jin H, Lovell JF, Corbin IR, Cao W, Lo P-C, Yang M, Tsao M-S, et al. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting. Small. 2010;6(3):430\u20137.","journal-title":"Small"},{"issue":"7","key":"2026_CR28","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1021\/nn400683s","volume":"7","author":"C Huang","year":"2013","unstructured":"Huang C, Jin H, Qian Y, Qi S, Luo H, Luo Q, Zhang Z. Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo. ACS Nano. 2013;7(7):5791\u2013800.","journal-title":"ACS Nano"},{"issue":"1","key":"2026_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41467-019-08538-x","volume":"10","author":"X Yu","year":"2019","unstructured":"Yu X, Chen L, Liu J, Dai B, Xu G, Shen G, Luo Q, Zhang Z. Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis. Nat Commun. 2019;10(1):574.","journal-title":"Nat Commun"},{"issue":"1","key":"2026_CR30","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41467-020-14906-9","volume":"11","author":"X Yu","year":"2020","unstructured":"Yu X, Dai Y, Zhao Y, Qi S, Liu L, Lu L, Luo Q, Zhang Z. Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response. Nat Commun. 2020;11(1):1110.","journal-title":"Nat Commun"},{"issue":"1","key":"2026_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41377-020-00399-0","volume":"9","author":"Y Dai","year":"2020","unstructured":"Dai Y, Yu X, Wei J, Zeng F, Li Y, Yang X, Luo Q, Zhang Z. Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles. Light Sci Appl. 2020;9(1):164.","journal-title":"Light Sci Appl"},{"key":"2026_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.addr.2019.09.005","volume":"151\u2013152","author":"X Ke","year":"2019","unstructured":"Ke X, Howard GP, Tang H, Cheng B, Saung MT, Santos JL, Mao H-Q. Physical and chemical profiles of nanoparticles for lymphatic targeting. Adv Drug Deliv Rev. 2019;151\u2013152:72\u201393.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"2026_CR33","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1158\/1541-7786.MCR-11-0156","volume":"9","author":"JMV Louderbough","year":"2011","unstructured":"Louderbough JMV, Schroeder JA. Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res. 2011;9(12):1573\u201386.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"2026_CR34","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1038\/s41467-019-11235-4","volume":"10","author":"T Tan","year":"2019","unstructured":"Tan T, Hu H, Wang H, Li J, Wang Z, Wang J, Wang S, Zhang Z, Li Y. Bioinspired lipoproteins-mediated photothermia remodels tumor stroma to improve cancer cell accessibility of second nanoparticles. Nat Commun. 2019;10(1):3322.","journal-title":"Nat Commun"},{"issue":"8","key":"2026_CR35","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","volume":"15","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15(8):e351\u201362.","journal-title":"Lancet Oncol"},{"key":"2026_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.fct.2014.03.022","volume":"68","author":"YJ Jeong","year":"2014","unstructured":"Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK, Choe JY, Bae YS, Han SM, Kim CH, Chang HW, Chang YC. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K\/Akt\/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol. 2014;68:218\u201325.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"2026_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41698-020-00129-0","volume":"4","author":"C Duffy","year":"2020","unstructured":"Duffy C, Sorolla A, Wang E, Golden E, Woodward E, Davern K, Ho D, Johnstone E, Pfleger K, Redfern A, et al. Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. npj Precis Oncol. 2020;4(1):24.","journal-title":"npj Precis Oncol"},{"issue":"11","key":"2026_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrd4608","volume":"14","author":"NL Trevaskis","year":"2015","unstructured":"Trevaskis NL, Kaminskas LM, Porter CJH. From sewer to saviour\u2014targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov. 2015;14(11):781\u2013803.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2026_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00262-003-0457-9","volume":"53","author":"PJ Russell","year":"2004","unstructured":"Russell PJ, Fau Hewish D, Carter T, Fau Carter T, Sterling-Levis K, Fau Sterling-Levis K, Ow K, Fau Ow K, Hattarki M, Fau Hattarki M, Doughty L, Fau Doughty L, Guthrie R, Fau Guthrie R, Shapira D, Fau Shapira D, Molloy PL, Fau Molloy Pl, Werkmeister JA, et al. Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies. Cancer Immunol Immunother. 2004;53(5):411\u201321.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"2026_CR40","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1096\/fj.09-153130","volume":"24","author":"H Pan","year":"2010","unstructured":"Pan H, Fau Myerson Jw, Ivashyna O, Fau Ivashyna O, Soman NR, Fau Soman Nr, Marsh JN, Fau Marsh Jn, Hood JL, Fau Hood Jl, Lanza GM, Fau Lanza Gm, Schlesinger PH, Fau Schlesinger Ph, Wickline SA, Wickline SA. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. FASEB J. 2010;24(8):2928\u201337.","journal-title":"FASEB J"},{"key":"2026_CR41","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11274-010-0491-7","volume":"27","author":"W Zhu","year":"2011","unstructured":"Zhu W, Zhou Y, Sun D, Li Z. An uPA cleavable conjugate of a recombinant \u03b1v\u03b23 targeting toxin and its bioactivity. World J Microbiol Biotechnol. 2011;27:563\u20139.","journal-title":"World J Microbiol Biotechnol"},{"issue":"6","key":"2026_CR42","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1021\/acsnano.2c02314","volume":"16","author":"C Ji","year":"2022","unstructured":"Ji C, Zhao M, Wang C, Liu R, Zhu S, Dong X, Su C, Gu Z. Biocompatible tantalum nanoparticles as radiosensitizers for enhancing therapy efficacy in primary tumor and metastatic sentinel lymph nodes. ACS Nano. 2022;16(6):9428\u201341.","journal-title":"ACS Nano"},{"issue":"29","key":"2026_CR43","doi-asserted-by":"publisher","first-page":"2200522","DOI":"10.1002\/smll.202200522","volume":"18","author":"X Wu","year":"2022","unstructured":"Wu X, Wang L, Xu Y-N, Chen J-L, Luo KQ, Yuan M-H, Li J, Yuan G, Gu Z-Y, Jia X-H, et al. Chemo-phototherapy with carfilzomib-encapsulated TiN nanoshells suppressing tumor growth and lymphatic metastasis. Small. 2022;18(29):2200522.","journal-title":"Small"},{"issue":"12","key":"2026_CR44","doi-asserted-by":"publisher","first-page":"14072","DOI":"10.1021\/acsami.1c25179","volume":"14","author":"M Xu","year":"2022","unstructured":"Xu M, Zhao D, Chen Y, Chen C, Zhang L, Sun L, Chen J, Tang Q, Sun S, Ma C, et al. Charge reversal polypyrrole nanocomplex-mediated gene delivery and photothermal therapy for effectively treating papillary thyroid cancer and inhibiting lymphatic metastasis. ACS Appl Mater Interfaces. 2022;14(12):14072\u201386.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"2026_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12951-023-01883-6","volume":"21","author":"X Wang","year":"2023","unstructured":"Wang X, Dai G, Jiang G, Zhang D, Wang L, Zhang W, Chen H, Cheng T, Zhou Y, Wei X, et al. A TMVP1-modified near-infrared nanoprobe: molecular imaging for tumor metastasis in sentinel lymph node and targeted enhanced photothermal therapy. J Nanobiotechnol. 2023;21(1):130.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"2026_CR46","doi-asserted-by":"publisher","first-page":"2200236","DOI":"10.1002\/adtp.202200236","volume":"6","author":"G Zhang","year":"2023","unstructured":"Zhang G, Cheng W, Yang N, Yang B, Yu S, Zheng J, Li M, Fu Y, Li X, Song Y, et al. Peptide-decorated artificial erythrocyte microvesicles endowed with lymph node targeting function for drug delivery. Adv Ther. 2023;6(6):2200236.","journal-title":"Adv Ther"},{"issue":"11","key":"2026_CR47","first-page":"3062","volume":"51","author":"T Utsugi","year":"1991","unstructured":"Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes1. Can Res. 1991;51(11):3062\u20136.","journal-title":"Can Res"},{"issue":"2","key":"2026_CR48","first-page":"1526","volume":"13","author":"Q Lin","year":"2019","unstructured":"Lin Q, Deng D, Song X, Dai B, Yang X, Luo Q, Zhang Z. Self-assembled \u201coff\/on\u201d nanopomegranate for in vivo photoacoustic and fluorescence imaging: strategic arrangement of kupffer cells in mouse hepatic lobules. ACS Nano. 2019;13(2):1526\u201337.","journal-title":"ACS Nano"},{"key":"2026_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1166\/jbn.2007.053","volume":"3","author":"IR Corbin","year":"2007","unstructured":"Corbin IR, Chen J, Cao W, Li H, Lund-Katz S, Zheng G. Enhanced cancer-targeted delivery using engineered high-density lipoprotein-based nanocarriers. J Biomed Nanotechnol. 2007;3:367.","journal-title":"J Biomed Nanotechnol"},{"issue":"6","key":"2026_CR50","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1096\/fj.10-174318","volume":"25","author":"H Luo","year":"2011","unstructured":"Luo H, Yang J, Jin H, Huang C, Fu J, Yang F, Gong H, Zeng S, Luo Q, Zhang Z. Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo. FASEB J. 2011;25(6):1865\u201373.","journal-title":"FASEB J"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-02026-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T10:02:46Z","timestamp":1690884166000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-02026-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2026"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-02026-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Huazhong University of Science & Technology Institutional Animal Care and Use Committee gave its permission to all procedures involving experimental animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests, financial or otherwise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}